Legal Challenge Looms: SINOVAC Board Warns Shareholders of Potential Roadblock to $55 Special Dividend
Sinovac, a leading biopharmaceutical company based in Beijing, is warning its shareholders of a new lawsuit that poses a significant threat to a proposed special dividend of $55.00 per share. This alert comes as Advantech/Prime Success, a party involved in ongoing legal matters with Sinovac, has filed a complaint that could complicate the distribution of the dividend intended for all eligible shareholders. The lawsuit potentially blocks the payment, raising concerns among investors who were eagerly anticipating the dividend. Affected shareholders may be left in uncertainty as they await further developments regarding the case. Sinovac has … Read more